The present invention refers to galactosylated peptides formed of 11-21 amino acids capable of identifying autoantibodies in autoimmune diseases such as Rheumatoid arthritis (RA), Juvenile RA, Systemic Lupus Erythematosus, Scleroderma, Sjogren's syndrome, and inflammatory bowel diseases, and therefore useful tools for diagnosis or therapeutic treatment of those pathologies, in particular RA.

Galactosylated peptides, their preparation and use in autoimmune diseases diagnosis / M.C. Alcaro; M. Chelli; F. Lolli; P. Migliorini; I. Paolini; A.M. Papini; P. Rovero.. - (2007).

Galactosylated peptides, their preparation and use in autoimmune diseases diagnosis

LOLLI, FRANCESCO;PAPINI, ANNA MARIA;ROVERO, PAOLO
2007

Abstract

The present invention refers to galactosylated peptides formed of 11-21 amino acids capable of identifying autoantibodies in autoimmune diseases such as Rheumatoid arthritis (RA), Juvenile RA, Systemic Lupus Erythematosus, Scleroderma, Sjogren's syndrome, and inflammatory bowel diseases, and therefore useful tools for diagnosis or therapeutic treatment of those pathologies, in particular RA.
M.C. Alcaro; M. Chelli; F. Lolli; P. Migliorini; I. Paolini; A.M. Papini; P. Rovero.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/369047
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact